chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Dysphagia, Fatigue, Injection site pain
Clinical narrative: Glands still hurt; Lymph nodes in groin area between; Swollen Lymph odes in Armpit; Swollen Lymph nodes in Neck; Blisters on her Tongue; Swollen Tongue; Hard to Swallow; Diarrhea (a little); Stomach Upset (a little); Fatigue; Pain in Upper Arm Injection Area and 3" surrounding; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE BLISTERING (Blisters on her Tongue), SWOLLEN TONGUE (Swollen Tongue), DYSPHAGIA (Hard to Swallow), DIARRHOEA (Diarrhea (a little)) and ABDOMINAL DISCOMFORT (Stomach Upset (a little)) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulfa).    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced TONGUE BLISTERING (Blisters on her Tongue), SWOLLEN TONGUE (Swollen Tongue), DYSPHAGIA (Hard to Swallow), DIARRHOEA (Diarrhea (a little)), ABDOMINAL DISCOMFORT (Stomach Upset (a little)), FATIGUE (Fatigue), INJECTION SITE PAIN (Pain in Upper Arm Injection Area and 3" surrounding), LYMPHADENOPATHY (Lymph nodes in groin area between), LYMPHADENOPATHY (Swollen Lymph odes in Armpit) and LYMPHADENOPATHY (Swollen Lymph nodes in Neck). On 17-Feb-2021, the patient experienced PAIN (Glands still hurt). On 16-Feb-2021, TONGUE BLISTERING (Blisters on her Tongue), SWOLLEN TONGUE (Swollen Tongue) and DYSPHAGIA (Hard to Swallow) had resolved. At the time of the report, DIARRHOEA (Diarrhea (a little)), ABDOMINAL DISCOMFORT (Stomach Upset (a little)), FATIGUE (Fatigue), INJECTION SITE PAIN (Pain in Upper Arm Injection Area and 3" surrounding), PAIN (Glands still hurt), LYMPHADENOPATHY (Lymph nodes in groin area between), LYMPHADENOPATHY (Swollen Lymph odes in Armpit) and LYMPHADENOPATHY (Swollen Lymph nodes in Neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Pain, Swollen tongue, Tongue blistering
Clinical narrative: Glands still hurt; Lymph nodes in groin area between; Swollen Lymph odes in Armpit; Swollen Lymph nodes in Neck; Blisters on her Tongue; Swollen Tongue; Hard to Swallow; Diarrhea (a little); Stomach Upset (a little); Fatigue; Pain in Upper Arm Injection Area and 3" surrounding; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE BLISTERING (Blisters on her Tongue), SWOLLEN TONGUE (Swollen Tongue), DYSPHAGIA (Hard to Swallow), DIARRHOEA (Diarrhea (a little)) and ABDOMINAL DISCOMFORT (Stomach Upset (a little)) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy (Sulfa).    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced TONGUE BLISTERING (Blisters on her Tongue), SWOLLEN TONGUE (Swollen Tongue), DYSPHAGIA (Hard to Swallow), DIARRHOEA (Diarrhea (a little)), ABDOMINAL DISCOMFORT (Stomach Upset (a little)), FATIGUE (Fatigue), INJECTION SITE PAIN (Pain in Upper Arm Injection Area and 3" surrounding), LYMPHADENOPATHY (Lymph nodes in groin area between), LYMPHADENOPATHY (Swollen Lymph odes in Armpit) and LYMPHADENOPATHY (Swollen Lymph nodes in Neck). On 17-Feb-2021, the patient experienced PAIN (Glands still hurt). On 16-Feb-2021, TONGUE BLISTERING (Blisters on her Tongue), SWOLLEN TONGUE (Swollen Tongue) and DYSPHAGIA (Hard to Swallow) had resolved. At the time of the report, DIARRHOEA (Diarrhea (a little)), ABDOMINAL DISCOMFORT (Stomach Upset (a little)), FATIGUE (Fatigue), INJECTION SITE PAIN (Pain in Upper Arm Injection Area and 3" surrounding), PAIN (Glands still hurt), LYMPHADENOPATHY (Lymph nodes in groin area between), LYMPHADENOPATHY (Swollen Lymph odes in Armpit) and LYMPHADENOPATHY (Swollen Lymph nodes in Neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Muscle tightness, Pruritus
Clinical narrative: Itchiness; His muscles have tightened up; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itchiness) and MUSCLE TIGHTNESS (His muscles have tightened up) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced PRURITUS (Itchiness) and MUSCLE TIGHTNESS (His muscles have tightened up). At the time of the report, PRURITUS (Itchiness) and MUSCLE TIGHTNESS (His muscles have tightened up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pyrexia, Somnolence, Tenderness
Clinical narrative: Fever of 99.4F; Fatigue; Slept all; swollen arm of injection site; very tender; black/blue bruise on same arm as injection site under elbow; This spontaneous case was reported by an other health care professional and describes the occurrence of TENDERNESS (very tender), VACCINATION SITE BRUISING (black/blue bruise on same arm as injection site under elbow), SOMNOLENCE (Slept all), VACCINATION SITE SWELLING (swollen arm of injection site) and PYREXIA (Fever of 99.4F) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced TENDERNESS (very tender), VACCINATION SITE BRUISING (black/blue bruise on same arm as injection site under elbow) and VACCINATION SITE SWELLING (swollen arm of injection site). On 16-Feb-2021, the patient experienced SOMNOLENCE (Slept all) and FATIGUE (Fatigue). On 17-Feb-2021, the patient experienced PYREXIA (Fever of 99.4F). At the time of the report, TENDERNESS (very tender), VACCINATION SITE BRUISING (black/blue bruise on same arm as injection site under elbow), SOMNOLENCE (Slept all), VACCINATION SITE SWELLING (swollen arm of injection site), PYREXIA (Fever of 99.4F) and FATIGUE (Fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 99.4 DF.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. The patient used warm compresses on the arm of the injection site to subside the pain of the black/blue bruise.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site bruising, Vaccination site swelling
Clinical narrative: Fever of 99.4F; Fatigue; Slept all; swollen arm of injection site; very tender; black/blue bruise on same arm as injection site under elbow; This spontaneous case was reported by an other health care professional and describes the occurrence of TENDERNESS (very tender), VACCINATION SITE BRUISING (black/blue bruise on same arm as injection site under elbow), SOMNOLENCE (Slept all), VACCINATION SITE SWELLING (swollen arm of injection site) and PYREXIA (Fever of 99.4F) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced TENDERNESS (very tender), VACCINATION SITE BRUISING (black/blue bruise on same arm as injection site under elbow) and VACCINATION SITE SWELLING (swollen arm of injection site). On 16-Feb-2021, the patient experienced SOMNOLENCE (Slept all) and FATIGUE (Fatigue). On 17-Feb-2021, the patient experienced PYREXIA (Fever of 99.4F). At the time of the report, TENDERNESS (very tender), VACCINATION SITE BRUISING (black/blue bruise on same arm as injection site under elbow), SOMNOLENCE (Slept all), VACCINATION SITE SWELLING (swollen arm of injection site), PYREXIA (Fever of 99.4F) and FATIGUE (Fatigue) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Feb-2021, Body temperature: 99.4 DF.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. The patient used warm compresses on the arm of the injection site to subside the pain of the black/blue bruise.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: warmness at the arm of injection; itchiness at the injection arm; Redness at the injection arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warmness at the arm of injection), VACCINATION SITE PRURITUS (itchiness at the injection arm) and VACCINATION SITE ERYTHEMA (Redness at the injection arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warmness at the arm of injection), VACCINATION SITE PRURITUS (itchiness at the injection arm) and VACCINATION SITE ERYTHEMA (Redness at the injection arm). At the time of the report, VACCINATION SITE WARMTH (warmness at the arm of injection), VACCINATION SITE PRURITUS (itchiness at the injection arm) and VACCINATION SITE ERYTHEMA (Redness at the injection arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Fatigue, Limb discomfort, Myalgia
Clinical narrative: left arm doesn't feel very good; left arm is more sore, sleeps on it at night and it is sore the next day right where the shots were; Shoulder pain over the last two weeks; Fatigue that lasted a day and a half; Started having trouble breathing after walking a flight of stairs; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Started having trouble breathing after walking a flight of stairs), LIMB DISCOMFORT (left arm doesn't feel very good), FATIGUE (Fatigue that lasted a day and a half), MYALGIA (left arm is more sore, sleeps on it at night and it is sore the next day right where the shots were) and ARTHRALGIA (Shoulder pain over the last two weeks) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.    On 04-Feb-2021 at 6:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced DYSPNOEA (Started having trouble breathing after walking a flight of stairs) and FATIGUE (Fatigue that lasted a day and a half). On an unknown date, the patient experienced LIMB DISCOMFORT (left arm doesn't feel very good), MYALGIA (left arm is more sore, sleeps on it at night and it is sore the next day right where the shots were) and ARTHRALGIA (Shoulder pain over the last two weeks). On 07-Feb-2021, FATIGUE (Fatigue that lasted a day and a half) had resolved. At the time of the report, DYSPNOEA (Started having trouble breathing after walking a flight of stairs), LIMB DISCOMFORT (left arm doesn't feel very good), MYALGIA (left arm is more sore, sleeps on it at night and it is sore the next day right where the shots were) and ARTHRALGIA (Shoulder pain over the last two weeks) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Additional initial document received
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Ultrasound foetal
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 29-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 022M20A) for COVID-19 vaccination.     The patient's past medical history included Live birth (Live, full-term birth with no complications for the mother or infant) on 09-Oct-2018.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 16-May-2020 and the estimated date of delivery was 16-Feb-2021. On 16-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fifth week of the pregnancy. The delivery occurred  on 15-Feb-2021, which was reported as Full-term. For neonate 1, the birth weight was 3175 grams (7lbs). The outcome was reported as Delivered NOS. Baby was born full term, no complications, healthy baby girl 7 lbs 7 oz. On 16-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Jun-2020, Pregnancy test: positive (Positive) Positive. On 02-Feb-2021, Ultrasound foetal: normal (normal) Normal.         Estimated date of conception: 19-May-2020.  No concomitant medication provided.  No treatment medication provided.   This case was linked to MOD-2021-008774 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Follow up received on 9-JUN-2021 and Updated pregnancy details, patient history, lab data, suspect product details, event onset date and patient demographics.
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Influenza like illness, Pain in extremity
Clinical narrative: Flu-like symptoms; Pain in the arm; Feeling very tired; This spontaneous case was reported by a physician and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (Pain in the arm) and FATIGUE (Feeling very tired) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (Pain in the arm) and FATIGUE (Feeling very tired). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), PAIN IN EXTREMITY (Pain in the arm) and FATIGUE (Feeling very tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported. On 16-FEB-2021, the patient tested for IgG and IgM through fast RNA COVID qualitative NAAT (nucleic acid amplification test). The test results stated IgG and IgM antibodies were not detected.   Most recent FOLLOW-UP information incorporated above includes: On 18-Feb-2021: Additional initial document received.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Myalgia, Pyrexia, Rhinorrhoea
Clinical narrative: Muscle Aches; Low grade Fever 98.8 Fahrenheit; May Have Sinus Infection; Nasal discharge (green and blody); sneezing a little; Tired; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (May Have Sinus Infection), SNEEZING (sneezing a little), RHINORRHOEA (Nasal discharge (green and blody)), MYALGIA (Muscle Aches) and PYREXIA (Low grade Fever 98.8 Fahrenheit) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 0416O20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Muscle ache on 01-Jan-2021.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced SNEEZING (sneezing a little) and FATIGUE (Tired). On 16-Feb-2021, the patient experienced SINUSITIS (May Have Sinus Infection), RHINORRHOEA (Nasal discharge (green and blody)) and PYREXIA (Low grade Fever 98.8 Fahrenheit). On an unknown date, the patient experienced MYALGIA (Muscle Aches). At the time of the report, SINUSITIS (May Have Sinus Infection), SNEEZING (sneezing a little), RHINORRHOEA (Nasal discharge (green and blody)), PYREXIA (Low grade Fever 98.8 Fahrenheit) and FATIGUE (Tired) outcome was unknown and MYALGIA (Muscle Aches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature: 98.8 DF.         Concomitant medications were not provided. The patient received acetaminophen for muscle ache.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis, Sneezing
Clinical narrative: Muscle Aches; Low grade Fever 98.8 Fahrenheit; May Have Sinus Infection; Nasal discharge (green and blody); sneezing a little; Tired; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (May Have Sinus Infection), SNEEZING (sneezing a little), RHINORRHOEA (Nasal discharge (green and blody)), MYALGIA (Muscle Aches) and PYREXIA (Low grade Fever 98.8 Fahrenheit) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 0416O20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Muscle ache on 01-Jan-2021.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced SNEEZING (sneezing a little) and FATIGUE (Tired). On 16-Feb-2021, the patient experienced SINUSITIS (May Have Sinus Infection), RHINORRHOEA (Nasal discharge (green and blody)) and PYREXIA (Low grade Fever 98.8 Fahrenheit). On an unknown date, the patient experienced MYALGIA (Muscle Aches). At the time of the report, SINUSITIS (May Have Sinus Infection), SNEEZING (sneezing a little), RHINORRHOEA (Nasal discharge (green and blody)), PYREXIA (Low grade Fever 98.8 Fahrenheit) and FATIGUE (Tired) outcome was unknown and MYALGIA (Muscle Aches) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Feb-2021, Body temperature: 98.8 DF.         Concomitant medications were not provided. The patient received acetaminophen for muscle ache.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Injection site erythema, Injection site pruritus
Clinical narrative: Wanted to sleep all day long; injection site arm site temperature is hot; injection site arm mild itching; injection site arm swelling; injection site arm redness; injection site arm under the arm painful; developed a headache; injection site arm swollen lymph node; Felt tired all day, just tired; Sore arm; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Wanted to sleep all day long), INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), MYALGIA (Sore arm) and HEADACHE (headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included KETOROLAC TROMETHAMINE (TORADOL) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced MYALGIA (Sore arm), HEADACHE (headache) and CHILLS (chills). On 10-Feb-2021, the patient experienced FATIGUE (Felt tired all day, just tired). On 17-Feb-2021, the patient experienced INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), INJECTION SITE SWELLING (injection site arm swelling), INJECTION SITE ERYTHEMA (injection site arm redness), VACCINATION SITE PAIN (injection site arm under the arm painful), HEADACHE (developed a headache) and VACCINATION SITE LYMPHADENOPATHY (injection site arm swollen lymph node). On an unknown date, the patient experienced SOMNOLENCE (Wanted to sleep all day long). At the time of the report, SOMNOLENCE (Wanted to sleep all day long) and CHILLS (chills) had resolved and INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), MYALGIA (Sore arm), HEADACHE (headache), FATIGUE (Felt tired all day, just tired), INJECTION SITE SWELLING (injection site arm swelling), INJECTION SITE ERYTHEMA (injection site arm redness), VACCINATION SITE PAIN (injection site arm under the arm painful), HEADACHE (developed a headache) and VACCINATION SITE LYMPHADENOPATHY (injection site arm swollen lymph node) outcome was unknown.            No treatment information was provided. The action taken for mRNA-1273 was not applicable.   This case was linked to MOD-2021-013647 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Follow up information and had significant information.  Reporter information, patient demographics, dosage information, new events  Somnolence and fatigue were updated.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Myalgia, Somnolence, Vaccination site lymphadenopathy
Clinical narrative: Wanted to sleep all day long; injection site arm site temperature is hot; injection site arm mild itching; injection site arm swelling; injection site arm redness; injection site arm under the arm painful; developed a headache; injection site arm swollen lymph node; Felt tired all day, just tired; Sore arm; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Wanted to sleep all day long), INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), MYALGIA (Sore arm) and HEADACHE (headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included KETOROLAC TROMETHAMINE (TORADOL) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced MYALGIA (Sore arm), HEADACHE (headache) and CHILLS (chills). On 10-Feb-2021, the patient experienced FATIGUE (Felt tired all day, just tired). On 17-Feb-2021, the patient experienced INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), INJECTION SITE SWELLING (injection site arm swelling), INJECTION SITE ERYTHEMA (injection site arm redness), VACCINATION SITE PAIN (injection site arm under the arm painful), HEADACHE (developed a headache) and VACCINATION SITE LYMPHADENOPATHY (injection site arm swollen lymph node). On an unknown date, the patient experienced SOMNOLENCE (Wanted to sleep all day long). At the time of the report, SOMNOLENCE (Wanted to sleep all day long) and CHILLS (chills) had resolved and INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), MYALGIA (Sore arm), HEADACHE (headache), FATIGUE (Felt tired all day, just tired), INJECTION SITE SWELLING (injection site arm swelling), INJECTION SITE ERYTHEMA (injection site arm redness), VACCINATION SITE PAIN (injection site arm under the arm painful), HEADACHE (developed a headache) and VACCINATION SITE LYMPHADENOPATHY (injection site arm swollen lymph node) outcome was unknown.            No treatment information was provided. The action taken for mRNA-1273 was not applicable.   This case was linked to MOD-2021-013647 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Follow up information and had significant information.  Reporter information, patient demographics, dosage information, new events  Somnolence and fatigue were updated.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Wanted to sleep all day long; injection site arm site temperature is hot; injection site arm mild itching; injection site arm swelling; injection site arm redness; injection site arm under the arm painful; developed a headache; injection site arm swollen lymph node; Felt tired all day, just tired; Sore arm; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Wanted to sleep all day long), INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), MYALGIA (Sore arm) and HEADACHE (headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included KETOROLAC TROMETHAMINE (TORADOL) for an unknown indication.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Feb-2021, the patient experienced MYALGIA (Sore arm), HEADACHE (headache) and CHILLS (chills). On 10-Feb-2021, the patient experienced FATIGUE (Felt tired all day, just tired). On 17-Feb-2021, the patient experienced INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), INJECTION SITE SWELLING (injection site arm swelling), INJECTION SITE ERYTHEMA (injection site arm redness), VACCINATION SITE PAIN (injection site arm under the arm painful), HEADACHE (developed a headache) and VACCINATION SITE LYMPHADENOPATHY (injection site arm swollen lymph node). On an unknown date, the patient experienced SOMNOLENCE (Wanted to sleep all day long). At the time of the report, SOMNOLENCE (Wanted to sleep all day long) and CHILLS (chills) had resolved and INJECTION SITE WARMTH (injection site arm site temperature is hot), INJECTION SITE PRURITUS (injection site arm mild itching), MYALGIA (Sore arm), HEADACHE (headache), FATIGUE (Felt tired all day, just tired), INJECTION SITE SWELLING (injection site arm swelling), INJECTION SITE ERYTHEMA (injection site arm redness), VACCINATION SITE PAIN (injection site arm under the arm painful), HEADACHE (developed a headache) and VACCINATION SITE LYMPHADENOPATHY (injection site arm swollen lymph node) outcome was unknown.            No treatment information was provided. The action taken for mRNA-1273 was not applicable.   This case was linked to MOD-2021-013647 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-May-2021: Follow up information and had significant information.  Reporter information, patient demographics, dosage information, new events  Somnolence and fatigue were updated.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Musculoskeletal discomfort, Nasopharyngitis
Clinical narrative: a slight cold; goes all down to the neck; woke up with a real bad cough and a head ache; woke up with a real bad cough and a head ache; This spontaneous case was reported by an other caregiver and describes the occurrence of NASOPHARYNGITIS (a slight cold), MUSCULOSKELETAL DISCOMFORT (goes all down to the neck), COUGH (woke up with a real bad cough and a head ache) and HEADACHE (woke up with a real bad cough and a head ache) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.    On 17-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced NASOPHARYNGITIS (a slight cold), MUSCULOSKELETAL DISCOMFORT (goes all down to the neck), COUGH (woke up with a real bad cough and a head ache) and HEADACHE (woke up with a real bad cough and a head ache). At the time of the report, NASOPHARYNGITIS (a slight cold), MUSCULOSKELETAL DISCOMFORT (goes all down to the neck), COUGH (woke up with a real bad cough and a head ache) and HEADACHE (woke up with a real bad cough and a head ache) outcome was unknown.            Concomitant medication also included not listed. Treatment information was not reported.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2020, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Dec-2020, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 02-Oct-2021. On 28-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). On 28-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Started to itch like a mosquito bite; Arm swelled around the injection site like size of a golf ball; Hardness around injection site; Still tender; potential allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Started to itch like a mosquito bite), HYPERSENSITIVITY (potential allergic reaction), VACCINATION SITE SWELLING (Arm swelled around the injection site like size of a golf ball), VACCINATION SITE INDURATION (Hardness around injection site) and VACCINATION SITE PAIN (Still tender) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Started to itch like a mosquito bite), VACCINATION SITE SWELLING (Arm swelled around the injection site like size of a golf ball), VACCINATION SITE INDURATION (Hardness around injection site) and VACCINATION SITE PAIN (Still tender). In February 2021, the patient experienced HYPERSENSITIVITY (potential allergic reaction). At the time of the report, VACCINATION SITE PRURITUS (Started to itch like a mosquito bite), VACCINATION SITE SWELLING (Arm swelled around the injection site like size of a golf ball), VACCINATION SITE INDURATION (Hardness around injection site) and VACCINATION SITE PAIN (Still tender) had not resolved and HYPERSENSITIVITY (potential allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.    This case was linked to MOD21-031843 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-Feb-2021: Additional initial document received
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Myalgia, Pyrexia
Clinical narrative: headache; high fever; chills; body aches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), PYREXIA (high fever), CHILLS (chills) and MYALGIA (body aches) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced HEADACHE (headache), PYREXIA (high fever), CHILLS (chills) and MYALGIA (body aches). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. On 30-Jan-2021, HEADACHE (headache), PYREXIA (high fever), CHILLS (chills) and MYALGIA (body aches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jan-2021, Body temperature: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (It is hot to the touch), RASH (traveled down to her arm as well), VACCINATION SITE PRURITUS (It itches), VACCINATION SITE RASH (It has a rash/ about 4-inch diameter) and VACCINATION SITE PAIN (It hurt at the injection) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (It hurt at the injection). On 03-Feb-2021, the patient experienced VACCINATION SITE WARMTH (It is hot to the touch), RASH (traveled down to her arm as well), VACCINATION SITE PRURITUS (It itches), VACCINATION SITE RASH (It has a rash/ about 4-inch diameter) and VACCINATION SITE ERYTHEMA (Rash was bright red). At the time of the report, VACCINATION SITE WARMTH (It is hot to the touch), RASH (traveled down to her arm as well), VACCINATION SITE PRURITUS (It itches), VACCINATION SITE RASH (It has a rash/ about 4-inch diameter), VACCINATION SITE PAIN (It hurt at the injection) and VACCINATION SITE ERYTHEMA (Rash was bright red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. No treatment information was provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (It is hot to the touch), RASH (traveled down to her arm as well), VACCINATION SITE PRURITUS (It itches), VACCINATION SITE RASH (It has a rash/ about 4-inch diameter) and VACCINATION SITE PAIN (It hurt at the injection) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VACCINATION SITE PAIN (It hurt at the injection). On 03-Feb-2021, the patient experienced VACCINATION SITE WARMTH (It is hot to the touch), RASH (traveled down to her arm as well), VACCINATION SITE PRURITUS (It itches), VACCINATION SITE RASH (It has a rash/ about 4-inch diameter) and VACCINATION SITE ERYTHEMA (Rash was bright red). At the time of the report, VACCINATION SITE WARMTH (It is hot to the touch), RASH (traveled down to her arm as well), VACCINATION SITE PRURITUS (It itches), VACCINATION SITE RASH (It has a rash/ about 4-inch diameter), VACCINATION SITE PAIN (It hurt at the injection) and VACCINATION SITE ERYTHEMA (Rash was bright red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication was reported. No treatment information was provided.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Lip swelling, Swollen tongue
Clinical narrative: Upper lip had swollen; Swelling in back of tongue on right side; Swelling in back of tongue on left side; sore shoulder; This spontaneous case was reported by a patient and describes the occurrence of SWOLLEN TONGUE (Swelling in back of tongue on left side), SWOLLEN TONGUE (Swelling in back of tongue on right side), LIP SWELLING (Upper lip had swollen) and ARTHRALGIA (sore shoulder) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016m20a) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included HYDROCODONE and VITAMINS NOS for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced ARTHRALGIA (sore shoulder). On 13-Feb-2021, the patient experienced SWOLLEN TONGUE (Swelling in back of tongue on left side). On 14-Feb-2021, the patient experienced SWOLLEN TONGUE (Swelling in back of tongue on right side). On 15-Feb-2021, the patient experienced LIP SWELLING (Upper lip had swollen). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SWOLLEN TONGUE (Swelling in back of tongue on left side), SWOLLEN TONGUE (Swelling in back of tongue on right side), LIP SWELLING (Upper lip had swollen) and ARTHRALGIA (sore shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication taken by the patient included thyroid meds, gout meds, prostrate meds, stomach meds.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus
Clinical narrative: Redness; Itchiness and hotness in the arm; Itchiness and hotness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), PRURITUS (Itchiness and hotness in the arm) and FEELING HOT (Itchiness and hotness in the arm) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20V) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced ERYTHEMA (Redness), PRURITUS (Itchiness and hotness in the arm) and FEELING HOT (Itchiness and hotness in the arm). At the time of the report, ERYTHEMA (Redness), PRURITUS (Itchiness and hotness in the arm) and FEELING HOT (Itchiness and hotness in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication were not reported Treatment medication were not reported
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain, Swelling, Tenderness
Clinical narrative: Red and sorted spread; Swelling down to elbow; achy and tender arm; achy and tender arm; This spontaneous case was reported by a consumer and describes the occurrence of TENDERNESS (achy and tender arm), PAIN (achy and tender arm), ERYTHEMA (Red and sorted spread) and SWELLING (Swelling down to elbow) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MONTELUKAST SODIUM (SINGULAIR), ROSUVASTATIN, LEVOTHYROXINE SODIUM (SYNTHROID), VITAMIN D NOS, ASCORBIC ACID, ZINC (VITAMIN C + ZINC), POTASSIUM and COENZYME Q10 [UBIDECARENONE] for an unknown indication.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Feb-2021, the patient experienced TENDERNESS (achy and tender arm) and PAIN (achy and tender arm). On 16-Feb-2021, the patient experienced ERYTHEMA (Red and sorted spread) and SWELLING (Swelling down to elbow). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, TENDERNESS (achy and tender arm), PAIN (achy and tender arm), ERYTHEMA (Red and sorted spread) and SWELLING (Swelling down to elbow) outcome was unknown.            Additional concomitant medication included methane.  The patient used ice packs and Tylenol with both shots.   This case was linked to MOD-2021-015580 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: fever (no exact temperature reported); chills; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever (no exact temperature reported)) and CHILLS (chills) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LOSARTAN and EZETIMIBE (ZETIA) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced PYREXIA (fever (no exact temperature reported)) and CHILLS (chills). At the time of the report, PYREXIA (fever (no exact temperature reported)) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity
Clinical narrative: Achy; Sore arm; Feel tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Feel tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Achy), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Feel tired). At the time of the report, PAIN (Achy), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Feel tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Feb-2021 and was forwarded to Moderna on 18-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Feel tired) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Feb-2021, the patient experienced PAIN (Achy), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Feel tired). At the time of the report, PAIN (Achy), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Feel tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) and PAIN IN EXTREMITY (Sore arm) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced DIZZINESS (Dizzy) and PAIN IN EXTREMITY (Sore arm). On 17-Feb-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, DIZZINESS (Dizzy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On 18-Feb-2021, the patient was dizzy again but not very bad. No concomitant medications were reported. No treatment medications were reported.